Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,717 public trials 2,164 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, not recruiting

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

NCT04106349

Conditions
Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +14 more
Locations
  • Onze-Lieve-vrouw Ziekenhuis Aalst Aalst, Belgium
  • Imeldaziekenhuis Bonheiden, Belgium
  • Clinique Saint-Luc Bouge Bouge, Belgium
  • AZ Sint-Jan Brugge Bruges, Belgium
View all 20 locations
View Trial Details
Active, not recruiting

Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

NCT04626479

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California at San Francisco ( Site 1008) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1011) New Haven, Connecticut, United States
  • University of Chicago ( Site 1013) Chicago, Illinois, United States
  • University of Iowa ( Site 1012) Iowa City, Iowa, United States
View all 55 locations
View Trial Details
Active, not recruiting

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

NCT03647878

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Landeskrankenhaus Hochsteiermark Leoben, Austria
  • Kepler Universitätsklinikum GmbH Linz, Austria
  • Uniklinikum Salzburg Salzburg, Austria
  • Salzkammergutklinikum Vöcklabruck Vöcklabruck, Austria
View all 82 locations
View Trial Details
Active, not recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details

Related conditions